Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and  Scripps Research, the ...

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...

Want to B-positive about your health? Johns Hopkins researchers have developed a cutting-edge blood test that can detect signs of cancer three years before any symptoms surface.

This is where a new type of test comes in. FDA recently approved the first blood test for colon cancer screening in adults ages 45 and older at average risk for the disease.

And there is another test that many people don’t ask for that can help catch cancer early: a complete blood count (CBC) test.

Doctors at Allegheny Health Network are hailing a groundbreaking study as a “game-changer” in cancer detection.

The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

This month, the FDA gave “Breakthrough Device Designation” to a new blood test by Guardian Health for detection of eight tumor types: colorectal, lung, liver, pancreatic, ovarian, esophageal, gastric ...

Researchers at Johns Hopkins University are developing a promising blood test that could identify cancer up to three years before symptoms emerge, potentially revolutionizing early detection and ...